Hawaii HI
Neal Milner: Why The Latest Alzheimer's 'Breakthrough' May Offer False Hope
On June 7 the Food and Drug Administration approved the use of Adulhem, a new Alzheimer's medication. The FDA considers Adulhem a breakthrough drug that will go on the market in th…
